Integra Lifesciences Holdings

Integra Lifesciences Holdings is a leading global medical technology company that develops, manufactures, and markets a comprehensive portfolio of surgical implants, instruments, equipment, and supplies. Through its subsidiaries, particularly Integra Lifesciences Corporation (doing business as Jarit), the company provides specialized medical devices to various federal government agencies. These products primarily focus on neurosurgery, orthopedics, and reconstructive surgery. Integra Lifesciences Holdings has been registered to receive federal contract awards since 2002, demonstrating a long-standing relationship with government healthcare providers.

The company has received numerous federal contract awards, primarily from the Department of Veterans Affairs, Department of Health and Human Services, Department of Defense, and Indian Health Service. These awards include purchase orders and delivery orders for a wide range of medical products and services. Notable items supplied include surgical implants, tissue ablation systems, brain probe kits, skull clamps, surgical headlights, and various specialized medical instruments and equipment. Integra has also provided preventative maintenance and repair services for medical equipment. Significant contracts include a $249,500 purchase order for the INFINITY SYSTEM from the VA, a $418,783 contract for a CUSA Clarity Ultrasonic Tissue Ablation System from the NIH Clinical Center, and multiple orders for brain probe kits from the Navy Bureau of Medicine and Surgery. Additionally, Integra Lifesciences Corporation has acted as a subcontractor to Cardinal Health 200, LLC, supplying medical and surgical equipment under Defense Logistics Agency contracts. No set-aside designations were used for the reviewed contract awards.

Integra Lifesciences Holdings currently holds two significant federal contract Indefinite Delivery Vehicles (IDVs). The first is a single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract with the Department of the Navy Bureau of Medicine and Surgery, valued at $346,857.80, for the procurement of Integra Probe Kit 2 Plus brain probe kits compatible with Integra Licox oxygen monitors. This contract, awarded on May 10, 2023, runs through May 9, 2028, and supports neurological research at the Naval Medical Research Unit in San Antonio, Texas. The second IDV is a Blanket Purchase Agreement (BPA) with the Indian Health Service, awarded on August 20, 2019, with a ceiling value of $150,000 for surgical supplies as needed. This BPA was established to support the Indian Health Service's mission of providing healthcare services to Native Americans and had a performance period through August 31, 2020. These IDVs highlight Integra Lifesciences Holdings' role as a key supplier of specialized medical equipment and supplies to federal healthcare agencies, particularly in support of neurological research and Native American healthcare initiatives.